Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial

NCT07293260 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

406

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiovascular Disease

Interventions

DRUG: Olpasiran
DRUG: Placebo

Sponsor

Amgen